Updated PVC-13 Vaccine Guidelines in Older Adults
Pneumococcal vaccine guidelines have changed over time in the United States. A new study published in the journal Vaccine involved more than a million U.S. veterans and sought to test the effectiveness of the pneumococcal conjugate vaccine (PCV-13), the pneumococcal polysaccharide vaccine (PPSV-23), and dual vaccination. The study confirmed the effectiveness of PCV-13. Read more.

Shingles Vaccine Rates Low in European Oncologic, Hematologic Patients
A new study decries the low rates of vaccination with the inactivated varicella-zoster vaccine, Shingrix, in European patients with oncologic and hematologic conditions. Find out how few of the patients have received the vaccine, which has shown strong effectiveness, and why the authors believe that might be the case.

Surveys Add to Understanding of Vaccine Hesitancy During Pandemic
While vaccine hesitancy was especially acute earlier in the COVID-19 pandemic before and shortly after vaccines were approved, it is a problem that persists in the United States. In an effort to better understand what keeps people from receiving proven vaccines, researchers conducted a series of surveys. Learn more about what they found.